TYRA-430 is an oral, investigational FGFR4/3-biased inhibitor for FGF19 + /FGFR4-driven cancers. The US Food and Drug Administration has cleared Tyra's Investigational New Drug application to ...

TYRA-430 is an oral, investigational FGFR4/3-biased inhibitor for FGF19+/FGFR4-driven cancers. The US Food and Drug Administration has cleared Tyra's Investigational New Drug application to ...

Nina S. Kjellson, a director at Tyra Biosciences , Inc. (NASDAQ:TYRA), recently made several transactions involving the sale of common stock in the company. According to a recent SEC filing ...

Tyra Banks is among the thousands of people in Los Angeles who have been impacted by the still-active wildfires that have swept through the area, but she’s thankful that most of her cherished ...

“I just didn’t want to pull a lot of attention to me,” she said. “I feel like there’s a lot of people that need that attention, so I haven’t really talked about it." By Lexy Perez ...

Hey, I'm Ryan Pearson. I'm an entertainment video manager for the Associated Press in Los Angeles. And um I am back at my house in Al Sadina for the first time since the day of the fires.